Global Follicle Stimulating Hormone (FSH) Injections Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 113

Published Date: 08 Feb 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Follicle Stimulating Hormone (FSH) Injections market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.

Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.

The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.

The Global Info Research report includes an overview of the development of the Follicle Stimulating Hormone (FSH) Injections industry chain, the market status of IVF and Embryo Transfer (Powder, Liquid), Infertility Treatment (Powder, Liquid), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Follicle Stimulating Hormone (FSH) Injections.

Regionally, the report analyzes the Follicle Stimulating Hormone (FSH) Injections markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Follicle Stimulating Hormone (FSH) Injections market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Follicle Stimulating Hormone (FSH) Injections market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Follicle Stimulating Hormone (FSH) Injections industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Powder, Liquid).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Follicle Stimulating Hormone (FSH) Injections market.

Regional Analysis: The report involves examining the Follicle Stimulating Hormone (FSH) Injections market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Follicle Stimulating Hormone (FSH) Injections market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Follicle Stimulating Hormone (FSH) Injections:
Company Analysis: Report covers individual Follicle Stimulating Hormone (FSH) Injections manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Follicle Stimulating Hormone (FSH) Injections This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (IVF and Embryo Transfer, Infertility Treatment).

Technology Analysis: Report covers specific technologies relevant to Follicle Stimulating Hormone (FSH) Injections. It assesses the current state, advancements, and potential future developments in Follicle Stimulating Hormone (FSH) Injections areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Follicle Stimulating Hormone (FSH) Injections market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Follicle Stimulating Hormone (FSH) Injections market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Market segment by Type
    by Injection Type
        Powder
        Liquid
    by Source of Ingredients
        Recombinant FSH (rFSH)
        Urinary FSH (uFSH)

Market segment by Application
    IVF and Embryo Transfer
    Infertility Treatment

Major players covered
    Gonal-F (Merck)
    Follistim (Organon)
    Bravelle (Ferring)
    Menopur (Ferring)
    Fostimon (IBSA)
    Puregon (Organon)
    BEMFOLA (Gedeon Richter)
    Follitrope (LG Chem)
    Livzon
    GenSci

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Follicle Stimulating Hormone (FSH) Injections product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Follicle Stimulating Hormone (FSH) Injections, with price, sales, revenue and global market share of Follicle Stimulating Hormone (FSH) Injections from 2019 to 2024.
Chapter 3, the Follicle Stimulating Hormone (FSH) Injections competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Follicle Stimulating Hormone (FSH) Injections breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Follicle Stimulating Hormone (FSH) Injections market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Follicle Stimulating Hormone (FSH) Injections.
Chapter 14 and 15, to describe Follicle Stimulating Hormone (FSH) Injections sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Follicle Stimulating Hormone (FSH) Injections
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Powder
        1.3.3 Liquid
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 IVF and Embryo Transfer
        1.4.3 Infertility Treatment
    1.5 Global Follicle Stimulating Hormone (FSH) Injections Market Size & Forecast
        1.5.1 Global Follicle Stimulating Hormone (FSH) Injections Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity (2019-2030)
        1.5.3 Global Follicle Stimulating Hormone (FSH) Injections Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Gonal-F (Merck)
        2.1.1 Gonal-F (Merck) Details
        2.1.2 Gonal-F (Merck) Major Business
        2.1.3 Gonal-F (Merck) Follicle Stimulating Hormone (FSH) Injections Product and Services
        2.1.4 Gonal-F (Merck) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Gonal-F (Merck) Recent Developments/Updates
    2.2 Follistim (Organon)
        2.2.1 Follistim (Organon) Details
        2.2.2 Follistim (Organon) Major Business
        2.2.3 Follistim (Organon) Follicle Stimulating Hormone (FSH) Injections Product and Services
        2.2.4 Follistim (Organon) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Follistim (Organon) Recent Developments/Updates
    2.3 Bravelle (Ferring)
        2.3.1 Bravelle (Ferring) Details
        2.3.2 Bravelle (Ferring) Major Business
        2.3.3 Bravelle (Ferring) Follicle Stimulating Hormone (FSH) Injections Product and Services
        2.3.4 Bravelle (Ferring) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Bravelle (Ferring) Recent Developments/Updates
    2.4 Menopur (Ferring)
        2.4.1 Menopur (Ferring) Details
        2.4.2 Menopur (Ferring) Major Business
        2.4.3 Menopur (Ferring) Follicle Stimulating Hormone (FSH) Injections Product and Services
        2.4.4 Menopur (Ferring) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Menopur (Ferring) Recent Developments/Updates
    2.5 Fostimon (IBSA)
        2.5.1 Fostimon (IBSA) Details
        2.5.2 Fostimon (IBSA) Major Business
        2.5.3 Fostimon (IBSA) Follicle Stimulating Hormone (FSH) Injections Product and Services
        2.5.4 Fostimon (IBSA) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Fostimon (IBSA) Recent Developments/Updates
    2.6 Puregon (Organon)
        2.6.1 Puregon (Organon) Details
        2.6.2 Puregon (Organon) Major Business
        2.6.3 Puregon (Organon) Follicle Stimulating Hormone (FSH) Injections Product and Services
        2.6.4 Puregon (Organon) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Puregon (Organon) Recent Developments/Updates
    2.7 BEMFOLA (Gedeon Richter)
        2.7.1 BEMFOLA (Gedeon Richter) Details
        2.7.2 BEMFOLA (Gedeon Richter) Major Business
        2.7.3 BEMFOLA (Gedeon Richter) Follicle Stimulating Hormone (FSH) Injections Product and Services
        2.7.4 BEMFOLA (Gedeon Richter) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
    2.8 Follitrope (LG Chem)
        2.8.1 Follitrope (LG Chem) Details
        2.8.2 Follitrope (LG Chem) Major Business
        2.8.3 Follitrope (LG Chem) Follicle Stimulating Hormone (FSH) Injections Product and Services
        2.8.4 Follitrope (LG Chem) Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 Follitrope (LG Chem) Recent Developments/Updates
    2.9 Livzon
        2.9.1 Livzon Details
        2.9.2 Livzon Major Business
        2.9.3 Livzon Follicle Stimulating Hormone (FSH) Injections Product and Services
        2.9.4 Livzon Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Livzon Recent Developments/Updates
    2.10 GenSci
        2.10.1 GenSci Details
        2.10.2 GenSci Major Business
        2.10.3 GenSci Follicle Stimulating Hormone (FSH) Injections Product and Services
        2.10.4 GenSci Follicle Stimulating Hormone (FSH) Injections Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 GenSci Recent Developments/Updates

3 Competitive Environment: Follicle Stimulating Hormone (FSH) Injections by Manufacturer
    3.1 Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Follicle Stimulating Hormone (FSH) Injections Revenue by Manufacturer (2019-2024)
    3.3 Global Follicle Stimulating Hormone (FSH) Injections Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Follicle Stimulating Hormone (FSH) Injections by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Follicle Stimulating Hormone (FSH) Injections Manufacturer Market Share in 2023
        3.4.2 Top 6 Follicle Stimulating Hormone (FSH) Injections Manufacturer Market Share in 2023
    3.5 Follicle Stimulating Hormone (FSH) Injections Market: Overall Company Footprint Analysis
        3.5.1 Follicle Stimulating Hormone (FSH) Injections Market: Region Footprint
        3.5.2 Follicle Stimulating Hormone (FSH) Injections Market: Company Product Type Footprint
        3.5.3 Follicle Stimulating Hormone (FSH) Injections Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Follicle Stimulating Hormone (FSH) Injections Market Size by Region
        4.1.1 Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Region (2019-2030)
        4.1.2 Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Region (2019-2030)
        4.1.3 Global Follicle Stimulating Hormone (FSH) Injections Average Price by Region (2019-2030)
    4.2 North America Follicle Stimulating Hormone (FSH) Injections Consumption Value (2019-2030)
    4.3 Europe Follicle Stimulating Hormone (FSH) Injections Consumption Value (2019-2030)
    4.4 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Consumption Value (2019-2030)
    4.5 South America Follicle Stimulating Hormone (FSH) Injections Consumption Value (2019-2030)
    4.6 Middle East and Africa Follicle Stimulating Hormone (FSH) Injections Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2030)
    5.2 Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Type (2019-2030)
    5.3 Global Follicle Stimulating Hormone (FSH) Injections Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2030)
    6.2 Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Application (2019-2030)
    6.3 Global Follicle Stimulating Hormone (FSH) Injections Average Price by Application (2019-2030)

7 North America
    7.1 North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2030)
    7.2 North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2030)
    7.3 North America Follicle Stimulating Hormone (FSH) Injections Market Size by Country
        7.3.1 North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2019-2030)
        7.3.2 North America Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2030)
    8.2 Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2030)
    8.3 Europe Follicle Stimulating Hormone (FSH) Injections Market Size by Country
        8.3.1 Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2019-2030)
        8.3.2 Europe Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Market Size by Region
        9.3.1 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2030)
    10.2 South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2030)
    10.3 South America Follicle Stimulating Hormone (FSH) Injections Market Size by Country
        10.3.1 South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2019-2030)
        10.3.2 South America Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Market Size by Country
        11.3.1 Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Follicle Stimulating Hormone (FSH) Injections Market Drivers
    12.2 Follicle Stimulating Hormone (FSH) Injections Market Restraints
    12.3 Follicle Stimulating Hormone (FSH) Injections Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Follicle Stimulating Hormone (FSH) Injections and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Follicle Stimulating Hormone (FSH) Injections
    13.3 Follicle Stimulating Hormone (FSH) Injections Production Process
    13.4 Follicle Stimulating Hormone (FSH) Injections Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Follicle Stimulating Hormone (FSH) Injections Typical Distributors
    14.3 Follicle Stimulating Hormone (FSH) Injections Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Table 2. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Table 3. Gonal-F (Merck) Basic Information, Manufacturing Base and Competitors
    Table 4. Gonal-F (Merck) Major Business
    Table 5. Gonal-F (Merck) Follicle Stimulating Hormone (FSH) Injections Product and Services
    Table 6. Gonal-F (Merck) Follicle Stimulating Hormone (FSH) Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 7. Gonal-F (Merck) Recent Developments/Updates
    Table 8. Follistim (Organon) Basic Information, Manufacturing Base and Competitors
    Table 9. Follistim (Organon) Major Business
    Table 10. Follistim (Organon) Follicle Stimulating Hormone (FSH) Injections Product and Services
    Table 11. Follistim (Organon) Follicle Stimulating Hormone (FSH) Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 12. Follistim (Organon) Recent Developments/Updates
    Table 13. Bravelle (Ferring) Basic Information, Manufacturing Base and Competitors
    Table 14. Bravelle (Ferring) Major Business
    Table 15. Bravelle (Ferring) Follicle Stimulating Hormone (FSH) Injections Product and Services
    Table 16. Bravelle (Ferring) Follicle Stimulating Hormone (FSH) Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 17. Bravelle (Ferring) Recent Developments/Updates
    Table 18. Menopur (Ferring) Basic Information, Manufacturing Base and Competitors
    Table 19. Menopur (Ferring) Major Business
    Table 20. Menopur (Ferring) Follicle Stimulating Hormone (FSH) Injections Product and Services
    Table 21. Menopur (Ferring) Follicle Stimulating Hormone (FSH) Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 22. Menopur (Ferring) Recent Developments/Updates
    Table 23. Fostimon (IBSA) Basic Information, Manufacturing Base and Competitors
    Table 24. Fostimon (IBSA) Major Business
    Table 25. Fostimon (IBSA) Follicle Stimulating Hormone (FSH) Injections Product and Services
    Table 26. Fostimon (IBSA) Follicle Stimulating Hormone (FSH) Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 27. Fostimon (IBSA) Recent Developments/Updates
    Table 28. Puregon (Organon) Basic Information, Manufacturing Base and Competitors
    Table 29. Puregon (Organon) Major Business
    Table 30. Puregon (Organon) Follicle Stimulating Hormone (FSH) Injections Product and Services
    Table 31. Puregon (Organon) Follicle Stimulating Hormone (FSH) Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 32. Puregon (Organon) Recent Developments/Updates
    Table 33. BEMFOLA (Gedeon Richter) Basic Information, Manufacturing Base and Competitors
    Table 34. BEMFOLA (Gedeon Richter) Major Business
    Table 35. BEMFOLA (Gedeon Richter) Follicle Stimulating Hormone (FSH) Injections Product and Services
    Table 36. BEMFOLA (Gedeon Richter) Follicle Stimulating Hormone (FSH) Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 37. BEMFOLA (Gedeon Richter) Recent Developments/Updates
    Table 38. Follitrope (LG Chem) Basic Information, Manufacturing Base and Competitors
    Table 39. Follitrope (LG Chem) Major Business
    Table 40. Follitrope (LG Chem) Follicle Stimulating Hormone (FSH) Injections Product and Services
    Table 41. Follitrope (LG Chem) Follicle Stimulating Hormone (FSH) Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 42. Follitrope (LG Chem) Recent Developments/Updates
    Table 43. Livzon Basic Information, Manufacturing Base and Competitors
    Table 44. Livzon Major Business
    Table 45. Livzon Follicle Stimulating Hormone (FSH) Injections Product and Services
    Table 46. Livzon Follicle Stimulating Hormone (FSH) Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 47. Livzon Recent Developments/Updates
    Table 48. GenSci Basic Information, Manufacturing Base and Competitors
    Table 49. GenSci Major Business
    Table 50. GenSci Follicle Stimulating Hormone (FSH) Injections Product and Services
    Table 51. GenSci Follicle Stimulating Hormone (FSH) Injections Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
    Table 52. GenSci Recent Developments/Updates
    Table 53. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Manufacturer (2019-2024) & (K Units)
    Table 54. Global Follicle Stimulating Hormone (FSH) Injections Revenue by Manufacturer (2019-2024) & (USD Million)
    Table 55. Global Follicle Stimulating Hormone (FSH) Injections Average Price by Manufacturer (2019-2024) & (US$/Unit)
    Table 56. Market Position of Manufacturers in Follicle Stimulating Hormone (FSH) Injections, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
    Table 57. Head Office and Follicle Stimulating Hormone (FSH) Injections Production Site of Key Manufacturer
    Table 58. Follicle Stimulating Hormone (FSH) Injections Market: Company Product Type Footprint
    Table 59. Follicle Stimulating Hormone (FSH) Injections Market: Company Product Application Footprint
    Table 60. Follicle Stimulating Hormone (FSH) Injections New Market Entrants and Barriers to Market Entry
    Table 61. Follicle Stimulating Hormone (FSH) Injections Mergers, Acquisition, Agreements, and Collaborations
    Table 62. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Region (2019-2024) & (K Units)
    Table 63. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Region (2025-2030) & (K Units)
    Table 64. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Region (2019-2024) & (USD Million)
    Table 65. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Region (2025-2030) & (USD Million)
    Table 66. Global Follicle Stimulating Hormone (FSH) Injections Average Price by Region (2019-2024) & (US$/Unit)
    Table 67. Global Follicle Stimulating Hormone (FSH) Injections Average Price by Region (2025-2030) & (US$/Unit)
    Table 68. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2024) & (K Units)
    Table 69. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2025-2030) & (K Units)
    Table 70. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Type (2019-2024) & (USD Million)
    Table 71. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Type (2025-2030) & (USD Million)
    Table 72. Global Follicle Stimulating Hormone (FSH) Injections Average Price by Type (2019-2024) & (US$/Unit)
    Table 73. Global Follicle Stimulating Hormone (FSH) Injections Average Price by Type (2025-2030) & (US$/Unit)
    Table 74. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2024) & (K Units)
    Table 75. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2025-2030) & (K Units)
    Table 76. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Application (2019-2024) & (USD Million)
    Table 77. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Application (2025-2030) & (USD Million)
    Table 78. Global Follicle Stimulating Hormone (FSH) Injections Average Price by Application (2019-2024) & (US$/Unit)
    Table 79. Global Follicle Stimulating Hormone (FSH) Injections Average Price by Application (2025-2030) & (US$/Unit)
    Table 80. North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2024) & (K Units)
    Table 81. North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2025-2030) & (K Units)
    Table 82. North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2024) & (K Units)
    Table 83. North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2025-2030) & (K Units)
    Table 84. North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2019-2024) & (K Units)
    Table 85. North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2025-2030) & (K Units)
    Table 86. North America Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2019-2024) & (USD Million)
    Table 87. North America Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2025-2030) & (USD Million)
    Table 88. Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2024) & (K Units)
    Table 89. Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2025-2030) & (K Units)
    Table 90. Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2024) & (K Units)
    Table 91. Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2025-2030) & (K Units)
    Table 92. Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2019-2024) & (K Units)
    Table 93. Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2025-2030) & (K Units)
    Table 94. Europe Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2019-2024) & (USD Million)
    Table 95. Europe Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2025-2030) & (USD Million)
    Table 96. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2024) & (K Units)
    Table 97. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2025-2030) & (K Units)
    Table 98. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2024) & (K Units)
    Table 99. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2025-2030) & (K Units)
    Table 100. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Region (2019-2024) & (K Units)
    Table 101. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Region (2025-2030) & (K Units)
    Table 102. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Consumption Value by Region (2019-2024) & (USD Million)
    Table 103. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Consumption Value by Region (2025-2030) & (USD Million)
    Table 104. South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2024) & (K Units)
    Table 105. South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2025-2030) & (K Units)
    Table 106. South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2024) & (K Units)
    Table 107. South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2025-2030) & (K Units)
    Table 108. South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2019-2024) & (K Units)
    Table 109. South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Country (2025-2030) & (K Units)
    Table 110. South America Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2019-2024) & (USD Million)
    Table 111. South America Follicle Stimulating Hormone (FSH) Injections Consumption Value by Country (2025-2030) & (USD Million)
    Table 112. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2019-2024) & (K Units)
    Table 113. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Type (2025-2030) & (K Units)
    Table 114. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2019-2024) & (K Units)
    Table 115. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Application (2025-2030) & (K Units)
    Table 116. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Region (2019-2024) & (K Units)
    Table 117. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity by Region (2025-2030) & (K Units)
    Table 118. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Consumption Value by Region (2019-2024) & (USD Million)
    Table 119. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Consumption Value by Region (2025-2030) & (USD Million)
    Table 120. Follicle Stimulating Hormone (FSH) Injections Raw Material
    Table 121. Key Manufacturers of Follicle Stimulating Hormone (FSH) Injections Raw Materials
    Table 122. Follicle Stimulating Hormone (FSH) Injections Typical Distributors
    Table 123. Follicle Stimulating Hormone (FSH) Injections Typical Customers
List of Figures
    Figure 1. Follicle Stimulating Hormone (FSH) Injections Picture
    Figure 2. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
    Figure 3. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value Market Share by Type in 2023
    Figure 4. Powder Examples
    Figure 5. Liquid Examples
    Figure 6. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
    Figure 7. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value Market Share by Application in 2023
    Figure 8. IVF and Embryo Transfer Examples
    Figure 9. Infertility Treatment Examples
    Figure 10. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value, (USD Million): 2019 & 2023 & 2030
    Figure 11. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value and Forecast (2019-2030) & (USD Million)
    Figure 12. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity (2019-2030) & (K Units)
    Figure 13. Global Follicle Stimulating Hormone (FSH) Injections Average Price (2019-2030) & (US$/Unit)
    Figure 14. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Manufacturer in 2023
    Figure 15. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value Market Share by Manufacturer in 2023
    Figure 16. Producer Shipments of Follicle Stimulating Hormone (FSH) Injections by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
    Figure 17. Top 3 Follicle Stimulating Hormone (FSH) Injections Manufacturer (Consumption Value) Market Share in 2023
    Figure 18. Top 6 Follicle Stimulating Hormone (FSH) Injections Manufacturer (Consumption Value) Market Share in 2023
    Figure 19. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Region (2019-2030)
    Figure 20. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value Market Share by Region (2019-2030)
    Figure 21. North America Follicle Stimulating Hormone (FSH) Injections Consumption Value (2019-2030) & (USD Million)
    Figure 22. Europe Follicle Stimulating Hormone (FSH) Injections Consumption Value (2019-2030) & (USD Million)
    Figure 23. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Consumption Value (2019-2030) & (USD Million)
    Figure 24. South America Follicle Stimulating Hormone (FSH) Injections Consumption Value (2019-2030) & (USD Million)
    Figure 25. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Consumption Value (2019-2030) & (USD Million)
    Figure 26. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Type (2019-2030)
    Figure 27. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value Market Share by Type (2019-2030)
    Figure 28. Global Follicle Stimulating Hormone (FSH) Injections Average Price by Type (2019-2030) & (US$/Unit)
    Figure 29. Global Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Application (2019-2030)
    Figure 30. Global Follicle Stimulating Hormone (FSH) Injections Consumption Value Market Share by Application (2019-2030)
    Figure 31. Global Follicle Stimulating Hormone (FSH) Injections Average Price by Application (2019-2030) & (US$/Unit)
    Figure 32. North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Type (2019-2030)
    Figure 33. North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Application (2019-2030)
    Figure 34. North America Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Country (2019-2030)
    Figure 35. North America Follicle Stimulating Hormone (FSH) Injections Consumption Value Market Share by Country (2019-2030)
    Figure 36. United States Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 37. Canada Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 38. Mexico Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 39. Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Type (2019-2030)
    Figure 40. Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Application (2019-2030)
    Figure 41. Europe Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Country (2019-2030)
    Figure 42. Europe Follicle Stimulating Hormone (FSH) Injections Consumption Value Market Share by Country (2019-2030)
    Figure 43. Germany Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 44. France Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 45. United Kingdom Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 46. Russia Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 47. Italy Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 48. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Type (2019-2030)
    Figure 49. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Application (2019-2030)
    Figure 50. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Region (2019-2030)
    Figure 51. Asia-Pacific Follicle Stimulating Hormone (FSH) Injections Consumption Value Market Share by Region (2019-2030)
    Figure 52. China Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 53. Japan Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 54. Korea Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 55. India Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 56. Southeast Asia Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 57. Australia Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 58. South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Type (2019-2030)
    Figure 59. South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Application (2019-2030)
    Figure 60. South America Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Country (2019-2030)
    Figure 61. South America Follicle Stimulating Hormone (FSH) Injections Consumption Value Market Share by Country (2019-2030)
    Figure 62. Brazil Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 63. Argentina Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 64. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Type (2019-2030)
    Figure 65. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Application (2019-2030)
    Figure 66. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Sales Quantity Market Share by Region (2019-2030)
    Figure 67. Middle East & Africa Follicle Stimulating Hormone (FSH) Injections Consumption Value Market Share by Region (2019-2030)
    Figure 68. Turkey Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 69. Egypt Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 70. Saudi Arabia Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 71. South Africa Follicle Stimulating Hormone (FSH) Injections Consumption Value and Growth Rate (2019-2030) & (USD Million)
    Figure 72. Follicle Stimulating Hormone (FSH) Injections Market Drivers
    Figure 73. Follicle Stimulating Hormone (FSH) Injections Market Restraints
    Figure 74. Follicle Stimulating Hormone (FSH) Injections Market Trends
    Figure 75. Porters Five Forces Analysis
    Figure 76. Manufacturing Cost Structure Analysis of Follicle Stimulating Hormone (FSH) Injections in 2023
    Figure 77. Manufacturing Process Analysis of Follicle Stimulating Hormone (FSH) Injections
    Figure 78. Follicle Stimulating Hormone (FSH) Injections Industrial Chain
    Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 80. Direct Channel Pros & Cons
    Figure 81. Indirect Channel Pros & Cons
    Figure 82. Methodology
    Figure 83. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Follitrope (LG Chem)
Livzon
GenSci

Related Reports

Global Follicle Stimulating Hormone (FSH) Injections Supply, Demand and Key Producers, 2024-2030

Global Follicle Stimulating Hormone (FSH) Injections Supply, Demand and Key Producers, 2024-2030

date 08 Feb 2024

date Pharma & Healthcare

The global Follicle Stimulating Hormone (FSH) Injections market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

Follicle Stimulating Hormone (FSH) Injections

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>